RPL19 and prostate carcinoma: RPL19 protein expression was regarded as a prognostic marker for prostate cancer (27), and fecal RPL19 mRNA was found to be a biomarker for aggressive behavior and is associated with an unfavorable prognosis in colorectal cancer (28).